Roglimet 2mg/500mg/2mg Tablet

Roglimet 2mg/500mg/2mg Tablet is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels. Roglimet 2mg/500mg/2mg Tablet should be taken in the dose and duration as advised by your doctor. It must be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. Overdose may lead to low blood sugar (hypoglycemia). Some people may develop hypoglycemia (low blood sugar level) when this medicine is taken along with other antidiabetic medicines, alcohol or upon skipping a meal. Monitor your blood sugar levels regularly while taking it. Other common side effects of this medicine include nausea, taste changes, diarrhea, stomach pain, headache, edema (swelling), blurred vision, bone fracture, and respiratory tract infection. Before taking this medicine, inform your doctor if you have any kidney, liver or heart problems. Pregnant or breastfeeding women should also consult their doctor before taking it. Your doctor will check your kidney function tests before starting treatment with it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects.

• Treatment of Type 2 diabetes mellitus

Roglimet 2mg/500mg/2mg Tablet is a combination of three antidiabetic medicines: Glimepiride, Metformin and Rosiglitazone. \tThey work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity.

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Roglimet 2mg/500mg/2mg Tablet is to be taken with food.

• Hypoglycemia (low blood glucose level)
• Nausea
• Taste change
• Diarrhea
• Stomach pain
• Headache
• Edema (swelling)
• Weight gain
• Blurred vision
• Bone fracture
• Respiratory tract infection

AlcoholUNSAFE

It is unsafe to consume alcohol with Roglimet 2mg/500mg/2mg Tablet.

PregnancyCONSULT YOUR DOCTOR

Roglimet 2mg/500mg/2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feedingCONSULT YOUR DOCTOR

Information regarding the use of Roglimet 2mg/500mg/2mg Tablet during breastfeeding is not available. Please consult your doctor.

DrivingCAUTION

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

KidneyCAUTION

Roglimet 2mg/500mg/2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Roglimet 2mg/500mg/2mg Tablet may be needed. Please consult your doctor. Use of Roglimet 2mg/500mg/2mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

LiverCAUTION

Roglimet 2mg/500mg/2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Roglimet 2mg/500mg/2mg Tablet may be needed. Please consult your doctor. Inform your doctor if you develop any signs and symptoms of jaundice while taking this medicine.

Habit Forming

No

Therapeutic Class

Anti diabetic